AARD News

Pomerantz LLP Pursues Class Action Litigation Against Aardvark Therapeutics, Inc. – AARD

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD

Pomerantz LLP Initiates Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD

Levi & Korsinsky Notifies Aardvark Therapeutics, Inc. (AARD) Investors – Lead Plaintiff Deadline on October 13, 2026

Class Action Lawsuit Filed Against Aardvark Therapeutics, Inc. (AARD) – Recover Losses – Contact Levi & Korsinsky Before October 13, 2026

Class Action Lawsuit Filed: Aardvark Therapeutics, Inc. (AARD) – Join by October 13, 2026 – Contact Levi & Korsinsky

Levi & Korsinsky Urges Aardvark Therapeutics, Inc. (AARD) Shareholders to Act Before Lead Plaintiff Deadline October 13, 2026

AARD ALERT: Securities Fraud Class Action Launched Against Aardvark Therapeutics, Inc. – October 13, 2026 Deadline

Investors Urged to Contact Levi & Korsinsky for Information Before October 13, 2026 – Aardvark Therapeutics, Inc. (AARD)

Class Action Lawsuit Filed: Aardvark Therapeutics, Inc. (AARD) – Join by October 13, 2026 – Contact Levi & Korsinsky